Red Biotechnology Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Chronic Diseases And Rise In R&D Investments


Red Biotechnology Market


Red biotechnology refers to the application of biotechnology in human and animal healthcare. It involves production of therapeutics, diagnostics, regenerative medicines, biomaterials, medical devices, and other products used for treatment or prevention of diseases in humans or animals. Red biotechnology utilizes cell and tissue culture, bioinformatics, molecular tagging, DNA sequencing and genetic engineering to develop diagnostics tests, therapeutics, monoclonal antibodies, recombinant proteins, blood and vaccines.


Market Dynamics:
Red biotechnology market is primarily driven by increasing prevalence of chronic diseases globally. According to World Health Organization (WHO), chronic diseases accounted for approximately 70% of all deaths worldwide in 2020, equivalent to 41 million deaths annually. Cancer, cardiovascular diseases, diabetes, chronic respiratory diseases, and other noncommunicable diseases collectively are responsible for huge healthcare costs and reduced productivity. Rising geriatric population susceptible to age-related conditions also contributes to the market growth. According to UN estimates, the population aged 65 years and above is projected to grow from 703 million in 2019 to 1.5 billion in 2050.

Another key driver is increasing R&D investments in development of novel biologics and biosimilars. Biopharmaceutical companies are investing heavily in research of targeted therapies, antibody drug conjugates, cell and gene therapies to develop advanced treatment options. For instance, Amgen invested over US$ 4.5 billion in R&D in 2021 focusing on oncology, inflammation, cardiovascular,
Segment Analysis

The red biotechnology market is dominated by biopharmaceuticals segment. Biopharmaceuticals include therapeutic drugs and vaccines that are manufactured using biological sources like microbes, plants, animals and genetic engineering. This segment holds the largest share owing to increasing prevalence of chronic diseases and growing demand for advanced biologics and monoclonal antibody drugs for treating cancer, diabetes, cardiovascular diseases and other indications.

PEST Analysis

Political: Government regulations and funding for research promote growth of red biotechnology. Economic: Rising healthcare spending and increasing demand for low-cost biologics drive market growth. Social: Growing awareness about benefits of biologics and stem cell therapies fuel adoption. Technological: Advancements in genetic engineering, protein therapeutics and development of biosimilars support market expansion.

Key Takeaways

Global Red Biotechnology Market Demand is expected to grow from US$ 742.80 billion in 2023 to US$ 1.3 trillion by 2030, exhibiting a CAGR of 10.7% over the forecast period. The biopharmaceuticals segment dominates owing to high demand for therapeutic drugs and monoclonal antibodies. Regionally, North America holds the largest share due to presence of major players and technological advancements. However, Asia Pacific is emerging as the fastest growing market due to increasing R&D spending and strengthening healthcare infrastructure.

Key players operating in the red biotechnology market are Amgen, Gilead Sciences, Biogen, Pfizer, Novartis, Roche, Johnson & Johnson, Sanofi, Merck & Co., AbbVie, GlaxoSmithKline, AstraZeneca, Eli Lilly, Novo Nordisk, Bayer, Bristol-Myers Squibb, Teva Pharmaceutical, Takeda Pharmaceutical, Boehringer Ingelheim, Astellas Pharma. These players are focusing on developing innovative therapies and biosimilars through collaborations and acquisitions. 

Comments

Post a Comment

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

Image
Security Robot Market The Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Security Robot Market encompasses advanced robotic technologies that are specifically designed and developed to enhance security and surveillance operations. These robots are equipped with features such as video surveillance, thermal imaging, facial recognition, and intrusion detection, among others. They are extensively used by security agencies and organizations across various sectors, including residential, commercial, industrial, and government, to enhance safety, reduce human intervention, and streamline security operations. Security robots offer real-time monitoring, remote control, and high accuracy, making them an ideal choice for surveillance in sensitive areas and remote locations. Market Dynamics:
Read more

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides

Image
Monochloroacetic Acid (MCAA) Market The Monochloroacetic Acid (MCAA) Market is estimated to be valued at USD 676.52 Million in 2022 and is expected to exhibit a CAGR of 7.03% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Monochloroacetic Acid (MCAA) Market is driven by the increasing demand for surfactants and herbicides in several industries such as agriculture, pharmaceuticals, textiles, and personal care. MCAA is extensively used in the production of surfactants, herbicides, and carboxymethyl cellulose (CMC), which are essential in various applications. These applications include detergents, agrochemicals, pharmaceuticals, dyes, and cosmetics, among others. The versatile properties of MCAA, such as its ability to act as a raw material in the production of herbicides and surfactants, make it highly desirable in the market. Market Dynamics: The Monochloroacetic Acid (MCAA) Market is driven by two k
Read more

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Image
  Scottish Whisky Market The Scottish Whisky Market is a captivating landscape that has been evolving and transforming over the years. It is a world of tradition, craftsmanship, and heritage, where every drop of whisky tells a story. The history of Scottish whisky traces back centuries, with the earliest records dating back to the 15th century. Whisky production initially started in monasteries, where monks distilled spirits for medicinal purposes. Over time, whisky production moved from monastic settings to farms and then to commercial distilleries. This transition marked the beginning of an industry that would become synonymous with Scotland. Scottish Whisky Market Was Valued At US$ 4.97 Bn In 2018, And It Is Expected To Reach US$ 7.89 Bn By The End Of 2027, Exhibiting A CAGR Of 5.3% During The Forecast Period (2019 To 2027). One of the defining characteristics of the Scottish Whisky Market is its adherence to traditional production methods. Scotch whisky is made from malted b
Read more